Global Asthma and COPD drugs growth rates

asthma drugs growth rate

Average growth rate for Asthma and COPD drug is 1% spanning from 2010 to 2013

Average annual revenue for 2011 is US 26,000 million

Forecasted annual revenue for 2015 is US 26,000 million.

Have a Free Insight into the viability of your business here

You can find more growth rate charts here